Drug–Drug Interactions Between the Anti-Hepatitis C Virus 3D Regimen of Ombitasvir, Paritaprevir/Ritonavir, and Dasabuvir and Eight Commonly Used Medications in Healthy Volunteers
Crossref DOI link: https://doi.org/10.1007/s40262-016-0373-8
Published Online: 2016-02-19
Published Print: 2016-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Polepally, Akshanth R.
King, Jennifer R.
Ding, Bifeng
Shuster, Diana L.
Dumas, Emily O.
Khatri, Amit
Chiu, Yi-Lin
Podsadecki, Thomas J.
Menon, Rajeev M.
Funding for this research was provided by:
AbbVie
License valid from 2016-02-19